Evidence map›Paper›PMID 34979739›Full record

ArticleTurkish journal of pharmaceutical sciences2021

Investigation of the Genotoxic, Cytotoxic, Apoptotic, and Oxidant Effects of Olive Leaf Extracts on Liver Cancer Cell Lines.

Muhammed Yunus Bektay, Eray Metin Güler, Mustafa Gökçe, Mustafa Volkan Kızıltaş

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Differential Radiomodulating Action ofAntioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Muhammed Yunus BektayBezmialem Vakıf University Faculty of Pharmacy, Department of Clinical Pharmacy; Marmara University Institute of Health Sciences, Department of Clinical Pharmacy, İstanbul, Turkey.ORCID 0000-0003-2032-9957
Eray Metin GülerUniversity of Health Sciences, Hamidiye Faculty of Medicine, Department of Medical Biochemistry; Haydarpaşa Numune Health Application and Research Center, Department of Medical Biochemistry, İstanbul, Turkey.ORCID 0000-0003-4351-1719
Mustafa GökçeBezmialem Vakıf University Faculty of Pharmacy, Department of Parhmacology, İstanbul, Turkey.ORCID 0000-0003-4996-7370
Mustafa Volkan Kızıltaşİstanbul University Faculty of Pharmacy, Department of Analytical Chemistry, İstanbul, Turkey.ORCID 0000-0002-1067-5998
Bezmiâlem Vakıf Üniversitesi · TRHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRIstanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHepatocellular carcinoma (HCC) is the seventh most common cancer and the third leading cause of tumor-related deaths worldwide. Mechanisms underlying tumor onset, progression, and metastasis in the case of HCC have not been adequately studied. In this study, we aimed to investigate the genotoxic, cytotoxic, apoptotic and oxidant effects of olive leaf extract (OLE) on HCC cells. MATERIALS AND

methods

resultsApoptotic, genotoxic, cytotoxic, and oxidative effects of OLEs increased with the increasing concentrations as compared to controls in H4IIE cells (p<0.001).

conclusionThis is the first study to show a significant and selective cytotoxic activity of OLEs in the selected H4IIE cancer cell lines. OLEs could selectively increase the apoptotic damage and show anti-proliferative and pro-apoptotic properties against the H4IIE cells. They could be recommended as potential nutraceuticals in the prevention of cancer.

Indexed as

apoptosisgenotoxicityhepatocellular carcinomaoleuropeinOlive leafoxidative stress

Identifiers

PMID34979739
PMCPMC8744438
OpenAlexW3152012289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.